1. A.01 Relieving the burden of myasthenia gravis: eculizumab reduces exacerbation, hospitalization and rescue therapy rates. (5th June 2019) Authors: Siddiqi, Z; Howard, JF; Jacob, S; Guptill, JT; Meisel, A; Wiendl, H; Murai, H; Utsugisawa, K; Nowak, RJ; Fujita, KP; O'Brien, F; Patra, K; Muppidi, S Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A.01 Relieving the burden of myasthenia gravis: eculizumab reduces exacerbation, hospitalization and rescue therapy rates. (June 2019) Authors: Siddiqi, Z; Howard, JF; Jacob, S; Guptill, JT; Meisel, A; Wiendl, H; Murai, H; Utsugisawa, K; Nowak, RJ; Fujita, KP; O'Brien, F; Patra, K; Muppidi, S Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗